Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 13 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Athyros, Vasilios  [Clear All Filters]
Journal Article
Doumas, M., Papademetriou V., Athyros V., & Karagiannis A. (2015).  Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go.. Angiology. 66(10), 901-3.
Panagiotakos, D. B., Georgousopoulou E. N., Polychronopoulos E., Vassilakou T., Chrysohoou C., Pitsavos C., et al. (2013).  Beliefs and attitudes regarding cardiovascular disease risk factors: a health survey in 10,141 Greek men and women (2006-2012).. Int J Cardiol. 168(5), 4847-9.
Reklou, A., Katsiki N., Karagiannis A., & Athyros V. (2019).  Effects of lipid lowering drugs on arterial stiffness. One more way to reduce cardiovascular risk?. Curr Vasc Pharmacol.
Achimastos, A., Alexandrides T., Alexopoulos D., Athyros V., Bargiota A., Bilianou E., et al. (2016).  Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.. Hormones (Athens). 15(1), 8-14.
Rizos, C. V., Athyros V., Bilianou E., Chrousos G., Garoufi A., Kolovou G., et al. (2017).  An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).. Hormones (Athens). 16(3), 306-312.
Rizos, C. V., Athyros V., Bilianou E., Chrousos G., Garoufi A., Kolovou G., et al. (2017).  An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).. Hormones (Athens). 16(3), 200-204.
Didangelos, T. P., Arsos G., Karamitsos T., Iliadis F., Papageorgiou A., Moralidis E., et al. (2014).  Left ventricular systolic and diastolic function in normotensive type 2 diabetic patients with or without autonomic neuropathy: a radionuclide ventriculography study.. Angiology. 65(10), 877-82.
Kotsis, V., Jordan J., Micic D., Finer N., Leitner D. R., Toplak H., et al. (2018).  Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension. J Hypertens. 36(7), 1427-1440.
Kotsis, V., Tsioufis K., Antza C., Seravalle G., Coca A., Sierra C., et al. (2018).  Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, ea. J Hypertens. 36(7), 1441-1455.
Patoulias, D., Stavropoulos K., Imprialos K., Athyros V., Doumas M., & Karagiannis A. (2019).  Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice. Curr Vasc Pharmacol.
Doumas, M., Athyros V., & Papademetriou V. (2015).  Screening for Primary Aldosteronism: Whom and How?. J Clin Hypertens (Greenwich). 17(7), 547-8.
Imprialos, K., Faselis C., Boutari C., Stavropoulos K., Athyros V., Karagiannis A., et al. (2017).  SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature.. Curr Pharm Des. 23(10), 1510-1521.
Doumas, M., Athyros V., & Karagiannis A. (2015).  Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?. Cardiology. 131(3), 186-8.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές